Literature DB >> 31011700

Fibrinogen and fibrin: An illustrated review.

Marlien Pieters1, Alisa S Wolberg2.   

Abstract

Since its discovery over 350 years ago, studies of fibrinogen have revealed remarkable characteristics. Its complex structure as a large (340 kDa) hexameric homodimer supports complex roles in hemostasis and homeostasis. Fibrinogen synthesis is regulated at the transcriptional and translational levels, undergoing both constitutive (basal) secretion from liver, and inducible upregulation in response to inflammatory events. In addition, alternative splicing yields fibrinogen variants with unique properties and contributions to coagulation biochemistry. During coagulation, fibrinogen conversion to fibrin occurs via thrombin-mediated proteolytic cleavage that produces intermediate protofibrils and then mature fibers that provide remarkable biochemical and mechanical stability to clots. Fibrin formation, structure, and stability are regulated by various genetic, biochemical, and environmental factors, allowing for dynamic kinetics of fibrin formation and structure. Interactions between fibrinogen and/or fibrin and plasma proteins and receptors on platelets, leukocytes, endothelial cells, and other cells enable complex functions in hemostasis, thrombosis, pregnancy, inflammation, infection, cancer, and other pathologies. Disorders in fibrinogen concentration and/or function increase risk of bleeding, thrombosis, and infection. This illustrated review covers fundamental aspects of fibrinogen and fibrin biology, biochemistry, biophysics, epidemiology, and clinical applications. Continued efforts to enhance our understanding of fibrinogen and fibrin in these processes are likely to advance treatment and prevention of many human diseases.

Entities:  

Keywords:  factor XIII; fibrin; fibrinogen; fibrinolysis; hemostasis; infection; thrombosis

Year:  2019        PMID: 31011700      PMCID: PMC6462751          DOI: 10.1002/rth2.12191

Source DB:  PubMed          Journal:  Res Pract Thromb Haemost        ISSN: 2475-0379


Fibrinogen is a complex glycoprotein present in high concentrations in plasma. Fibrinogen is converted to fibrin, which stabilizes blood clots and promotes hemostasis. Fibrin structure and mechanical properties are modified by genetic and environmental factors. Fibrin(ogen) also contributes to thrombosis, host defense, inflammation, and wound healing.

RELATIONSHIP DISCLOSURE

The authors report no conflicts of interest to disclose.

AUTHOR CONTRIBUTION

M. Pieters and A.S. Wolberg developed the concepts and images, wrote the manuscript, and approved the final content.
  70 in total

1.  Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

Authors:  J P Collet; D Park; C Lesty; J Soria; C Soria; G Montalescot; J W Weisel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

2.  Stretching single fibrin fibers hampers their lysis.

Authors:  Wei Li; Tomas Lucioni; Rongzhong Li; Keith Bonin; Samuel S Cho; Martin Guthold
Journal:  Acta Biomater       Date:  2017-07-25       Impact factor: 8.947

3.  Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study.

Authors:  Joanna Cieslik; Sandra Mrozinska; Elżbieta Broniatowska; Anetta Undas
Journal:  Blood       Date:  2017-12-14       Impact factor: 22.113

Review 4.  The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate.

Authors:  J W Weisel; R I Litvinov
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-07

Review 5.  Fibrinogen gene regulation.

Authors:  Richard J Fish; Marguerite Neerman-Arbez
Journal:  Thromb Haemost       Date:  2012-07-26       Impact factor: 5.249

Review 6.  Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.

Authors:  Anetta Undas; Robert A S Ariëns
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-11       Impact factor: 8.311

7.  Physical determinants of fibrinolysis in single fibrin fibers.

Authors:  Igal Bucay; E Tim O'Brien; Steven D Wulfe; Richard Superfine; Alisa S Wolberg; Michael R Falvo; Nathan E Hudson
Journal:  PLoS One       Date:  2015-02-25       Impact factor: 3.240

Review 8.  Biophysical Mechanisms Mediating Fibrin Fiber Lysis.

Authors:  Nathan E Hudson
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

9.  Nonuniform Internal Structure of Fibrin Fibers: Protein Density and Bond Density Strongly Decrease with Increasing Diameter.

Authors:  Wei Li; Justin Sigley; Stephen R Baker; Christine C Helms; Mary T Kinney; Marlien Pieters; Peter H Brubaker; Roger Cubcciotti; Martin Guthold
Journal:  Biomed Res Int       Date:  2017-10-10       Impact factor: 3.411

10.  Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.

Authors:  Wael Sumaya; Lars Wallentin; Stefan K James; Agneta Siegbahn; Katja Gabrysch; Maria Bertilsson; Anders Himmelmann; Ramzi A Ajjan; Robert F Storey
Journal:  Eur Heart J       Date:  2018-04-01       Impact factor: 29.983

View more
  41 in total

1.  Screening of multiple hemoprotein-specific aptamers and their applications for the binding, quantification, and extraction of hemoproteins in a microfluidic system.

Authors:  Chih-Hung Wang; Gwo-Bin Lee
Journal:  Biomicrofluidics       Date:  2020-04-13       Impact factor: 2.800

2.  Effect of fibrin glue on the healing efficacy of deproteinized bovine bone and autologous bone in critical-sized calvarial defects in rats.

Authors:  Chengwei Tu; Aisha Bajwa; Andi Shi; Gang Wu; Jingxiao Wang
Journal:  Clin Oral Investig       Date:  2022-01-29       Impact factor: 3.573

3.  Harnessing biomolecules for bioinspired dental biomaterials.

Authors:  Nicholas G Fischer; Eliseu A Münchow; Candan Tamerler; Marco C Bottino; Conrado Aparicio
Journal:  J Mater Chem B       Date:  2020-08-04       Impact factor: 6.331

4.  Fibrinogen Is a Specific Trigger for Cytolytic Eosinophil Degranulation.

Authors:  Mackenzie E Coden; Lucas F Loffredo; Matthew T Walker; Brian M Jeong; Kiwon Nam; Bruce S Bochner; Hiam Abdala-Valencia; Sergejs Berdnikovs
Journal:  J Immunol       Date:  2019-12-09       Impact factor: 5.422

5.  A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice.

Authors:  Adam Miszta; Anna K Kopec; Asmita Pant; Lori A Holle; James R Byrnes; Daniel A Lawrence; Kirk C Hansen; Matthew J Flick; James P Luyendyk; Bas de Laat; Alisa S Wolberg
Journal:  Blood       Date:  2020-05-07       Impact factor: 22.113

6.  Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors.

Authors:  Kwok Leung Ong; Robyn L McClelland; Matthew A Allison; Mary Cushman; Parveen K Garg; Michael Y Tsai; Kerry-Anne Rye; Fatiha Tabet
Journal:  Metabolism       Date:  2021-01-07       Impact factor: 8.694

7.  Prognostic Significance of the Combination of Fibrinogen and Tumor Marker Index in Esophageal Squamous Cell Carcinoma Patients.

Authors:  Yufeng Qiao; Mingquan Ma; Hongdian Zhang; Zhentao Yu; Peng Tang
Journal:  Onco Targets Ther       Date:  2021-02-17       Impact factor: 4.147

8.  Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury.

Authors:  Lauren G Poole; Anna K Kopec; Dafna J Groeneveld; Asmita Pant; Kevin S Baker; Holly M Cline-Fedewa; Matthew J Flick; James P Luyendyk
Journal:  Blood       Date:  2021-05-06       Impact factor: 22.113

9.  Journal impact factor: Recent evaluation changes and Research and Practice in Thrombosis and Haemostasis.

Authors:  Brian Coughlin; Mary Cushman
Journal:  Res Pract Thromb Haemost       Date:  2021-07-17

10.  Inhibition of Fibrinolysis by Streptococcal Phage LysinSM1.

Authors:  Hyun Jung Ji; Yong Zhi; Ji Hee Lee; Ki Bum Ahn; Ho Seong Seo; Paul M Sullam
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.